{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:05:24Z","timestamp":1789851924582,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022690","name":"Breakthrough T1D","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022690","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Methods"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.crmeth.2026.101605","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:15:44Z","timestamp":1789658144000},"page":"101605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and application of nbLIBRA-seq for high-throughput discovery of antigen-specific nanobodies"],"prefix":"10.1016","author":[{"given":"Sabina","family":"Leonard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry T.","family":"Wasdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parastoo","family":"Amlashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Renken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Rathmell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin W.","family":"Spiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Wadzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivelin S.","family":"Georgiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1732-2682","authenticated-orcid":false,"given":"Kelsey","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crmeth.2026.101605_bib1","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/imr.13385","article-title":"Nanobody-based heavy chain antibodies and chimeric antibodies","volume":"328","author":"Koch-Nolte","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.crmeth.2026.101605_bib2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2026.101605_bib3","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.3390\/ijms24065994","article-title":"Nanobodies: A Review of Generation, Diagnostics and Therapeutics","volume":"24","author":"Jin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.crmeth.2026.101605_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","article-title":"The Therapeutic Potential of Nanobodies","volume":"34","author":"Jov\u010devska","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.crmeth.2026.101605_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13864","article-title":"A first-in-human, single and multiple dose study of lunsekimig, a novel anti-TSLP\/anti-IL-13 NANOBODY(R) compound, in healthy volunteers","volume":"17","author":"Deiteren","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.crmeth.2026.101605_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012726","article-title":"Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidate","volume":"20","author":"Ye","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.crmeth.2026.101605_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.crmeth.2026.101605_bib8","doi-asserted-by":"crossref","first-page":"E2646","DOI":"10.1073\/pnas.1604268113","article-title":"Durable antitumor responses to CD47 blockade require adaptive immune stimulation","volume":"113","author":"Sockolosky","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.crmeth.2026.101605_bib9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1186\/s12951-024-02900-y","article-title":"Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years","volume":"22","author":"Alexander","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.crmeth.2026.101605_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/prot.25497","article-title":"Comparative analysis of nanobody sequence and structure data","volume":"86","author":"Mitchell","year":"2018","journal-title":"Proteins"},{"key":"10.1016\/j.crmeth.2026.101605_bib11","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1016\/j.jmb.2018.09.002","article-title":"Structural Basis of Epitope Recognition by Heavy-Chain Camelid Antibodies","volume":"430","author":"Zavrtanik","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.crmeth.2026.101605_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/08923973.2015.1102934","article-title":"Single-domain antibodies for biomedical applications","volume":"38","author":"Krah","year":"2016","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.crmeth.2026.101605_bib13","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3389\/fimmu.2017.01603","article-title":"Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics","volume":"8","author":"Bannas","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.crmeth.2026.101605_bib14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/19420862.2015.1046648","article-title":"Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform","volume":"7","author":"Klarenbeek","year":"2015","journal-title":"mAbs"},{"key":"10.1016\/j.crmeth.2026.101605_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41594-018-0028-6","article-title":"Yeast surface display platform for rapid discovery of conformationally selective nanobodies","volume":"25","author":"McMahon","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.crmeth.2026.101605_bib16","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.105887.3","article-title":"Phage-displayed synthetic library and screening platform for nanobody discovery","volume":"14","author":"Xia","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.crmeth.2026.101605_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/toxins16090393","article-title":"Neutralizing Nanobodies against Venoms from Naja haje Species Captured in North Africa","volume":"16","author":"Mejri","year":"2024","journal-title":"Toxins"},{"key":"10.1016\/j.crmeth.2026.101605_bib18","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.cell.2019.11.003","article-title":"High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity","volume":"179","author":"Setliff","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.crmeth.2026.101605_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01560-24","article-title":"Antibody sequence determinants of viral antigen specificity","volume":"15","author":"Abu-Shmais","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.crmeth.2026.101605_bib20","article-title":"SARS-CoV-2 antibodies from children exhibit broad neutralization and belong to adult public clonotypes","volume":"4","author":"Wall","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.crmeth.2026.101605_bib21","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.str.2024.08.022","article-title":"Discovery and characterization of a pan-betacoronavirus S2-binding antibody","volume":"32","author":"Johnson","year":"2024","journal-title":"Structure"},{"key":"10.1016\/j.crmeth.2026.101605_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq0178","article-title":"Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus","volume":"8","author":"Voss","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.crmeth.2026.101605_bib23","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s11095-022-03282-2","article-title":"Transferrin Receptor Binding BBB-Shuttle Facilitates Brain Delivery of Anti-Abeta-Affibodies","volume":"39","author":"Faresj\u00f6","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.crmeth.2026.101605_bib24","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001787R","article-title":"Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1","volume":"35","author":"Stocki","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.crmeth.2026.101605_bib25","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1038\/s41467-022-30205-x","article-title":"Profiling of hMPV F-specific antibodies isolated from human memory B cells","volume":"13","author":"Xiao","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crmeth.2026.101605_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2023.101337","article-title":"Structural basis for respiratory syncytial virus and human metapneumovirus neutralization","volume":"61","author":"Miller","year":"2023","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.crmeth.2026.101605_bib27","series-title":"Viral Infections of Humans: Epidemiology and Control","first-page":"601","article-title":"Paramyxoviruses: Respiratory Syncytial Virus and Human Metapneumovirus","author":"Crowe","year":"2014"},{"key":"10.1016\/j.crmeth.2026.101605_bib28","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2022.2047144","article-title":"Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19","volume":"14","author":"Esparza","year":"2022","journal-title":"mAbs"},{"key":"10.1016\/j.crmeth.2026.101605_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1128\/AAC.01802-15","article-title":"Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection","volume":"60","author":"Detalle","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmeth.2026.101605_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/imm.13224","article-title":"Landscape of variable domain of heavy-chain-only antibody repertoire from alpaca","volume":"161","author":"Tu","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.crmeth.2026.101605_bib31","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1021\/ac501202d","article-title":"VHH phage-based competitive real-time immuno-polymerase chain reaction for ultrasensitive detection of ochratoxin A in cereal","volume":"86","author":"Liu","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.crmeth.2026.101605_bib32","article-title":"A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein","volume":"7","author":"Abu-Shmais","year":"2026","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.crmeth.2026.101605_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-69328-w","article-title":"Development of a potent monoclonal antibody for treatment of human metapneumovirus infections","volume":"17","author":"Harris","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crmeth.2026.101605_bib34","article-title":"Distinct types of VHHs in Alpaca","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.crmeth.2026.101605_bib35","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41598-020-57764-7","article-title":"Comparisons of the antibody repertoires of a humanized rodent and humans by high throughput sequencing","volume":"10","author":"Joyce","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crmeth.2026.101605_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1231623","article-title":"A comparison of the binding sites of antibodies and single-domain antibodies","volume":"14","author":"Gordon","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.crmeth.2026.101605_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2024.100865","article-title":"Nanobodies: From High-Throughput Identification to Therapeutic Development","volume":"23","author":"Fridy","year":"2024","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.crmeth.2026.101605_bib38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/protein\/gzy017","article-title":"Analysis of nanobody paratopes reveals greater diversity than classical antibodies","volume":"31","author":"Mitchell","year":"2018","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.crmeth.2026.101605_bib39","article-title":"Comparative analysis of CDR3 length-dependent patterns in VHHs","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.crmeth.2026.101605_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2025.106702","article-title":"Screening and functional characterization of nanobodies targeting the transferrin receptor","volume":"231","author":"Ding","year":"2025","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.crmeth.2026.101605_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/v16121951","article-title":"A hTfR1 Receptor-Specific VHH Antibody Neutralizes Pseudoviruses Expressing Glycoproteins from Junin and Machupo Viruses","volume":"16","author":"Kang","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.crmeth.2026.101605_bib42","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/jmbi.1997.1477","article-title":"The specific variable domain of camel heavy-chain antibodies is encoded in the germline","volume":"275","author":"Nguyen","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.crmeth.2026.101605_bib43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jgg.2022.04.010","article-title":"Characterization of heavy-chain antibody gene repertoires in Bactrian camels","volume":"50","author":"Liu","year":"2023","journal-title":"J. Genet. Genomics"},{"key":"10.1016\/j.crmeth.2026.101605_bib44","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.3390\/molecules16021776","article-title":"Diversity of phage-displayed libraries of peptides during panning and amplification","volume":"16","author":"Derda","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.crmeth.2026.101605_bib45","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41596-023-00930-8","article-title":"Production and use of antigen tetramers to study antigen-specific B cells","volume":"19","author":"Phelps","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.crmeth.2026.101605_bib49","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2203326119","article-title":"Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus","volume":"119","author":"Banerjee","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.crmeth.2026.101605_bib50","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2026.101605_bib51","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature12442","article-title":"Cross-neutralization of four paramyxoviruses by a human monoclonal antibody","volume":"501","author":"Corti","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2026.101605_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011584","article-title":"Structure-based design of a single-chain triple-disulfide-stabilized fusion-glycoprotein trimer that elicits high-titer neutralizing responses against human metapneumovirus","volume":"19","author":"Ou","year":"2023","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.crmeth.2026.101605_bib53","doi-asserted-by":"crossref","first-page":"W503","DOI":"10.1093\/nar\/gkn316","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis","volume":"36","author":"Brochet","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.crmeth.2026.101605_bib46","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/s41587-022-01232-2","article-title":"Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking","volume":"40","author":"Shiakolas","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.crmeth.2026.101605_bib47","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nprot.2014.039","article-title":"A general protocol for the generation of Nanobodies for structural biology","volume":"9","author":"Pardon","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.crmeth.2026.101605_bib48","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/978-1-61779-842-9_32","article-title":"IMGT((R)) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT\/V-QUEST and IMGT\/HighV-QUEST for NGS","volume":"882","author":"Alamyar","year":"2012","journal-title":"Methods Mol. Biol."}],"container-title":["Cell Reports Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667237526003061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667237526003061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:44:43Z","timestamp":1789850683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667237526003061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":53,"alternative-id":["S2667237526003061"],"URL":"https:\/\/doi.org\/10.1016\/j.crmeth.2026.101605","relation":{},"ISSN":["2667-2375"],"issn-type":[{"value":"2667-2375","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and application of nbLIBRA-seq for high-throughput discovery of antigen-specific nanobodies","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crmeth.2026.101605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101605"}}